Personalized

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine?

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine?

As 3D printing technology gains increased acceptance by pharmaceutical companies, clinical labs may see increased demand for pharmacogenomic testing Will doctors ever “print” prescription drugs for patients in the office? It sounds like science fiction, but research from University College London (UCL) indicates that the ability may be closer than we think and could lead …

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine? Read More »

Livestock Improvement: How Forward Pack and Sexed Semen Can Boost Genetic Gain |  MarketScreener

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener

Myriad’s MyRisk™ hereditary cancer test with RiskScore® provides personalized breast cancer risk assessment for women of all backgrounds SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model | MarketScreener Read More »

Global Pharmacogenomics Markets, Analysis and Forecast, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarrays DNA

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth

Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) — The report “Europe Precision Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End User” has been added to from ResearchAndMarkets.com offer. Europe Precision Diagnostics Market is expected to grow from US$23,317.64 million in 2022 to US$48,500.85 million by 2028. It …

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth Read More »